Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Discover what are the best high return investments available today. Equip yourself with knowledge to enhance your investment strategy.
25,106 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Snowflake’s stock dips after the company outlines a mixed outlook for 2026, signaling a slower path to profitability ...
As NVIDIA readies its GTC keynote, memory names MU and SNDK swing on speculation about a new inference chip that coul...
Anthropic has filed a federal lawsuit after being labeled a supply-chain risk by the government, arguing the move thr...
Oil climbs above triple digits as Strait of Hormuz tensions flare, pushing markets into a longer, volatile period. Th...
One staffing stock plunged 56% in the last year, but a large new stake worth almost $10 million could signal a forthc...
A quiet crisis is forming in the real estate lending world. This article explains the $3 trillion challenge, who feel...
As investors eye ngvc 2026, this guide breaks down the factors driving NGVC’s earnings, from store growth to margins ...
Two data-focused tech players, Palantir and BigBear.ai, report quarterly numbers that investors watch closely. This g...
AMD sits near a pivotal $420 level as first-quarter results underscore strong data-center demand and a bold AI-driven...
A former NASA robotics chief warns that the U.S. is betting on spectacle over practical automation. The piece examine...
The U.S. power grid isn’t a single machine. It’s three interconnections that rarely move power across regions, a flaw...